Jeff Aronin Outlines Chicago’s Unique Strengths in Bioscience
A recent study from Biotechnology Innovation Organization (BIO) and TEConomy Partners valued the annual economic impact of the U.S. bioscience industry at $2 trillion. Jeff Aronin, Chairman and CEO of Paragon Biosciences, thinks Chicago’s unique…